echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The first anniversary of the implementation of traditional Chinese medicine law: national medicine meets the opportunity

    The first anniversary of the implementation of traditional Chinese medicine law: national medicine meets the opportunity

    • Last Update: 2018-07-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [market analysis of chinapharma.com] July 1 is the first anniversary of the implementation of the law of traditional Chinese medicine, which is expected to be speeded up In this year, the country not only improved the cultural soft power, but also determined the position and direction of traditional Chinese medicine, better standardized the development of traditional Chinese medicine industry, and let the traditional Chinese medicine service present a blowout growth trend Industry experts pointed out one belt, one road, the strategy of traction, the global market of Chinese medicine also opened wider to the national pharmaceutical enterprises It is understood that the so-called ethnic medicine refers to the traditional medicine of Chinese ethnic minorities Experts in the industry roughly divide it into three categories: having rich clinical experience and forming a complete theoretical system of medicine, such as Tibetan medicine, Mongolian medicine, Uygur Medicine, Dai medicine, etc There are rich experience in diagnosis and treatment technology and drug application, but the theoretical system is not complete Such as Zhuang, Miao, Yi, Dong and other ethnic medicine Having experience in medical technology and drug practice, but no written and historical records, only giving by words and deeds, and retaining the national characteristics in drug use, such as water, Buyi, Elunchun, Bai and other national medicine In fact, in recent years, the development of these ethnic medicine undertakings has been included in many national important strategic plans, such as the development plan of Chinese medicine health services (2015-2020), the strategic planning outline of Chinese medicine development (2016-2030), and the introduction of the Chinese medicine law is a development opportunity for ethnic medicine The law of traditional Chinese medicine brings business opportunities to the national medicine industry, which is embodied in the transformation of traditional Chinese medicine clinic from examination and approval system to record system, the teacher can also obtain the qualification of traditional Chinese medicine doctor, and the traditional Chinese medicine compound preparation derived from the ancient classic prescription can be exempted from clinical application when applying for the drug approval number The industry said that at present, China's population is facing the wave of aging, and social public health expenditure is increasing For the national medicine industry, innovation will become the theme of enterprise development While seizing the opportunity, national pharmaceutical enterprises also need to keep ahead consciousness, innovate R & D chain, talent strategic training and continuous R & D investment on the way of innovation The development of national medicine can not be separated from the support of policy From the perspective of current policies, a series of favorable policies are not only conducive to national pharmaceutical enterprises to play their own advantages, but also help enterprises have the opportunity to show themselves on the world stage Therefore, for enterprises, how to take advantage of the policy for strategic adjustment and layout is a key point For example, Taiji Huoxiang Zhengqi liquid will take advantage of the five strategies to go to the world in an all-round way after opening millions of real world research work It includes borrowing the one belt, one road strategy, leveraging millions of data strategies, ordering the marketing strategy and borrowing standardized strategies for Chinese medicinal materials In recent years, the innovative research and development of national medicine has been paid more and more attention In this regard, key laboratories, research rooms and technology research centers related to ethnic medicine research have been established in China Many national pharmaceutical enterprises choose to cooperate with universities and research institutes to invest in scientific research and keep innovation and breakthrough The inheritance and development of national medicine is inseparable from talents However, the current national traditional Chinese medicine talents are facing the problems of lack of quantity and low overall level Therefore, for the industry and even the national pharmaceutical enterprises, it is urgent to strengthen the training and team building of national medical talents In addition, many national pharmaceutical enterprises actively participate in industry exchanges and social responsibility actions, and transform innovation achievements into representatives of social responsibility.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.